-
EP3385278
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3385278
| EP3385278 - FULL HUMAN ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 08.06.2020 Database last updated on 03.09.2024 | |
| Former | Request for examination was made Status updated on 07.09.2018 | ||
| Former | The international publication has been made Status updated on 15.06.2017 | Most recent event Tooltip | 25.10.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Eliteimmune Inc. Room S1406 International Joint Academy of Biomedicine No. 220 Dongting Road TEDA Tianjin 300457 / CN | [2018/41] | Inventor(s) | 01 /
ZHAO, Xuelian Room S1406 International Joint Academy of Biomedicine No. 220 Dongting Road TEDA Tianjin 300457 / CN | 02 /
LIU, Guohua Room S1406 International Joint Academy of Biomedicine No. 220 Dongting Road TEDA Tianjin 300457 / CN | 03 /
WANG, Quanying Room S1406 International Joint Academy of Biomedicine No. 220 Dongting Road TEDA Tianjin 300457 / CN | [2018/41] | Representative(s) | ABG Intellectual Property Law, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | [N/P] |
| Former [2018/41] | ABG Patentes, S.L. Avenida de Burgos, 16D Edificio Euromor 28036 Madrid / ES | Application number, filing date | 16869955.1 | 29.11.2016 | [2018/41] | WO2016CN107658 | Priority number, date | CN201510867051 | 30.11.2015 Original published format: CN201510867051 | CN20161136424 | 23.11.2016 Original published format: CN201611036424 | [2018/41] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017092645 | Date: | 08.06.2017 | Language: | ZH | [2017/23] | Type: | A1 Application with search report | No.: | EP3385278 | Date: | 10.10.2018 | Language: | EN | [2018/41] | Search report(s) | International search report - published on: | CN | 08.06.2017 | (Supplementary) European search report - dispatched on: | EP | 25.07.2018 | Classification | IPC: | C07K16/00, A61K39/395, C12N15/63, A61P31/12, C07K16/10 | [2018/41] | CPC: |
C07K16/1027 (EP,CN,KR,US);
A61K39/295 (US);
A61K39/395 (EP,US);
A61P31/14 (EP,US);
C07K16/00 (EP,US);
C12N15/63 (EP,KR,US);
G01N33/56983 (KR);
A61K2039/505 (KR);
A61K2039/55 (US);
A61K2039/6075 (US);
C07K2317/21 (EP,KR,US);
C07K2317/24 (CN);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/41] | Title | German: | VOLLSTÄNDIG HUMANER ANTIKÖRPER GEGEN DAS RESPIRATORISCHE SYNZYTIAL-VIRUS | [2018/41] | English: | FULL HUMAN ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS | [2018/41] | French: | ANTICORPS COMPLÈTEMENT HUMANISÉ CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL | [2018/41] | Entry into regional phase | 27.06.2018 | Translation filed | 27.06.2018 | National basic fee paid | 27.06.2018 | Search fee paid | 27.06.2018 | Designation fee(s) paid | 27.06.2018 | Examination fee paid | Examination procedure | 27.06.2018 | Examination requested [2018/41] | 27.06.2018 | Date on which the examining division has become responsible | 05.12.2018 | Amendment by applicant (claims and/or description) | 12.06.2020 | Despatch of a communication from the examining division (Time limit: M04) | 21.09.2020 | Reply to a communication from the examining division | 06.07.2022 | Despatch of a communication from the examining division (Time limit: M04) | 13.10.2022 | Reply to a communication from the examining division | Fees paid | Renewal fee | 25.10.2018 | Renewal fee patent year 03 | 25.10.2019 | Renewal fee patent year 04 | 26.10.2020 | Renewal fee patent year 05 | 29.10.2021 | Renewal fee patent year 06 | 21.10.2022 | Renewal fee patent year 07 | 25.10.2023 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY]US2005175986 (GROSS MITCHELL S [US], et al) [I] 1-17 * claims * [Y] 1-17; | [IY]WO2011020079 (CALMUNE CORP [US], et al) [I] 1-17 * claims * [Y] 1-17; | [IY]WO2011043643 (MEDIMMUNE LTD [GB], et al) [I] 1-17 * claims 1-7 * [Y] 1-17; | [IY]WO2012006596 (CALMUNE CORP [US], et al) [I] 1-17 * claims * [Y] 1-17; | [IY]WO2013095091 (AIMM THERAPEUTICS BV [NL]) [I] 1-17 * claims * [Y] 1-17; | [IY]WO2014159822 (REGENERON PHARMA [US]) [I] 1-17 * claims * [Y] 1-17; | [IY]WO2014170258 (CRUCELL HOLLAND BV [NL]) [I] 1-17 * claims * [Y] 1-17; | [IY] - LAURENT DETALLE ET AL, "Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, US, (20151005), vol. 60, no. 1, doi:10.1128/AAC.01802-15, ISSN 0066-4804, pages 6 - 13, XP055492645 [I] 1-17 * abstract * [Y] 1-17 DOI: http://dx.doi.org/10.1128/AAC.01802-15 | [IY] - J. E. SCHUSTER ET AL, "A Broadly Neutralizing Human Monoclonal Antibody Exhibits In Vivo Efficacy Against Both Human Metapneumovirus and Respiratory Syncytial Virus", JOURNAL OF INFECTIOUS DISEASES. JID, US, (20140526), vol. 211, no. 2, doi:10.1093/infdis/jiu307, ISSN 0022-1899, pages 216 - 225, XP055186010 [I] 1-17 * abstract * [Y] 1-17 DOI: http://dx.doi.org/10.1093/infdis/jiu307 |